chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue; Achy; This is a spontaneous report from a non-contactable consumer. An adult male patient of unspecified age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021, as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, the patient experienced fatigue and achy. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue and achy were resolved on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. Pertinent medical history or drug allergies/drug reactions were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of M-M-R II (lot # J013431, expiration date 24-OCT-2015)(dose, strength and route of administration were not reported). There was no concomitant medication reported. No adverse effects were reported. Additional information has been requested.
18OCT-22OCT91 fever 100-101; 22OCT91 seen in ER; 24OCT91 rash started; 26OCT91 seen by MD; 28OCT rash clear;
This retrospective pregnancy case was reported by a healthcare professional and described the occurrence of fever in a 33-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline) after pregnancy. Concurrent medical conditions included penicillin allergy. Pregnant and delivered baby 05 October 2012. On 25 October 2012 the subject received unspecified dose of FLULAVAL (unknown, left arm). The subject had delivered a baby on 05 October 2012 and she was breast feeding; details regarding the pregnancy and birth were not provided. On 26 October 2012, one day after vaccination with FLULAVAL, the subject experienced fever, chills, mastitis-r breast, and breast lump. The subject was treated with cephalexin. On or about 27 or 28 October 2012, 2 days after vaccination with FLULAVAL, the subject experienced 1 breast tenderness and arm weakness. On 31 October 2012, 6 days after vaccination with FLULAVAL, the subject experienced high fever of 102.3 degrees Fahrenheit. The subject was hospitalized on an unspecified date and discharged on 02 November 2012. The subject was treated with vancomycin. The subject was hospitalized and the healthcare professional considered the events were clinically significant (or requiring intervention). At the time of reporting the fever, chills, r breast mastitis and breast lump were improved; the high fever resolved on 02 November 2012 and left breast tenderness and left arm weakness resolved on 05 November 2012. The subject had been pregnant and delivered on 05 October 2012 and is breast feeding. She received FLULAVAL and developed a fever, chills, right side mastitis, lump was treated for a couple of days with outpatient oral cephalexin. Then she developed a high fever of 102.3 degrees Fahrenheit, breast tenderness on left side (side of arm with injection) with left arm weakness. She was hospitalized and started on a pic-line and discharged home receiving home intravenous therapy with vancomycin, weakness and left sided problems resolved as of 05 November 2012. No cultures no abscess seen on ultrasound. Please see case A10001266B regarding the baby and vaccine exposure via breast milk.
Pt recvd 3 doses of Engerix-B & reporter indicated 3rd dose was 2 months late due to pt non-compliance; pt has antibody titer=9.9RU;
Information has been received from a health professional ("nurse"), via a company representative concerning a 15 year old female who on approximately 14 Feb 2007 ("sometime last week") was vaccinated IM with a second dose of Gardasil vaccine (yeast) (the patient's first vaccination date was not reported). Concomitant suspect vaccinations included a dose of Varicella and hepatitis A vaccine (inactive). On approximately 14 Feb 2006 ("sometime last week"), the instant after getting the vaccinations, the patient developed a "swallowed" red arm 8-9cm long and 6 cm wide. At the time of the report, it was unknown if the patient had recovered. The patient sought unspecified medical attention. Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/14/2007. Information has been received from a health professional ("nurse"), via a company representative and a physician concerning a 15 year old female (weight 124.25%, height 66.5%) with codeine and sulfa allergies who on 16-FEB-2007 was vaccinated IM in the left arm with a second dose of GARDASIL (lot #656049/0187U) (the patient's first vaccination date was not reported). Concomitant suspect vaccinations on 16-FEB-2007 included the second dose of VARIVAX (lot # 654757/1257F), SC in the left arm and the first dose of VAQTA (lot #656017/1280F), IM in the right arm. Other concomitant medication was not reported. On 16-FEB-2006, the instant after getting the vaccinations, the patient developed a "swallowed" red arm 8-9 cm long and 6 cm wide (also reported as redness at the sie of the injection). The patient sought unspecified medical attention and was treated with ZYRTEC. On 16-FEB-2007, the patient recovered from the event. Additional information is not expected. This is in follow-up to report (s) previously submitted on 3/14/2007; 7/6/2007.  Information has been received from a health professional ("nurse"), via a company representative and a physician concerning a 15 year old female with codeine and sulfa allergies who on 16-FEB-2007 was vaccinated IM in the left arm with a second dose of GARDASIL (lot #656049/0187U) (the patient's first vaccination date was not reported).  Concomitant suspect vaccination on 16-FEB-2007 included the second dose of VARIVAX (lot # 654752/1257F), SC in the left arm.  Other concomitant medication included the first dose of VAQTA (lot #656017/1280F), IM in the right arm.  On 16-FEB-2006, the instant after getting the vaccinations, the patient developed a "swallowed" red arm 8-9 cm long and 6 cm wide (also reported as redness at the site of the injection).  The patient sought unspecified medical attention and was treated with ZYRTEC.  On 16-FEB-2007, the patient recovered from the event.  Additional information is not expected.
About six minutes after the vaccination, while sitting in the clinic, I experienced a feeling like I was about to lose consciousness, together with salivary gland activation and heavier breathing.  This lasted about one minute and I did not pass out.  But about 25 minutes later, while driving home (alone), I experienced the same thing but for about 5 or 6 minutes.  Fortunately I didn't pass out.  About an hour after the shot I felt sort of back to normal.
Red knot in leg (Rt thigh). Pt did experience fever and vomiting after injection at home. Warm compress, ibuprofen.
Felt I had the flu which I thought was normal given I had the vaccine, however when I began to have small bumps on my eyebrow, chin, cheek and mouth area my first response was aged acne until I began to itch and rubbed my left side and felt a circular rash.
5/16/05 client received vaccinations at 4PM. On 5/17/05 she presents in clinic reporting she noticed bumps on her left arm and left leg upon awakening at 7AM. 2hrs later bumps developed on right leg. Denies fever, n/v or difficulty breathing. Bumps are sparse and hive-like in appearance.
EXTREME IRRITABILITY, INCONSOLABLE CRYING, SWELLING AT INJECTION SITE, MILD FEVER, DIARRHEA; TREATED WITH CHILDREN'S TYLENOL; LASTED UNTIL THE NEXT DAY
Initial misuse report received from a healthcare professional  on 25 July 2013. A patient (no information was provided regarding the patient) received DTAP/IPV component of PENTACEL reconstituted with a separate ACTHIB instead of the ACTHIB component provided with the PENTACEL. No adverse event was reported. List of documents held by sender: none.
This spontaneous report was received from a female patient of unknown age via a company representative regarding herself. The representative stated she heard about this report, on Saturday, 22-MAR-2014, from a person who attended the American of Dermatology conference. The attendee at the conference told the representative that she received a dose of ZOSTAVAX (lot#, expiry not reported) on an unknown date about 3 months ago approximately in December 2013 and developed a pretty severe localized reaction, post vaccination. The patient showed her pictures. Representative stated she did not have any identifying patient information or health care provider information. The outcome of a pretty severe localized reaction, post vaccination. The patient showed her pictures. Representative stated she did not have any identifying patient information or health care provider information. The outcome of a pretty severe localized reaction is unknown. Causality was not reported. Additional information has been requested.
Got shot at 11am on 9/22/21. Felt fine till 11pm. Felt nauseous around 11pm. Went to sleep. Woke up at 2am on 9/23/21 throwing up, severe body aches, and headache. Threw up again at 3am. Finally cried myself back to sleep around 4am. Woke up at 8am. Still at 1:40pm feeling severe body aches. Severely sore arm since I got the vaccine also.
This spontaneous report as received from a pharmacist refers to unspecified number of patients  of unknown age and unknown gender. Patients concurrent conditions and relevant medical history was not reported. On an unknown date, unspecified number of patients were vaccinated with improperly stored doses RECOMBIVAX HB (lot number, dose, frequency and route unspecified). Concomitant medications were not reported. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with RECOMBIVAX HB was not reported. Product quality issue was not involved. This is one of the several reports from the same reporter. Additional information has been requested.
No adverse event; We had 4 patients that received the Moderna Covid-19 vaccine Monovalent, instead of the Moderna Covid-19 Vaccine, Bivalent booster dose.; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (We had 4 patients that received the Moderna Covid-19 vaccine Monovalent, instead of the Moderna Covid-19 Vaccine, Bivalent booster dose.) and NO ADVERSE EVENT (No adverse event) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 083B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (We had 4 patients that received the Moderna Covid-19 vaccine Monovalent, instead of the Moderna Covid-19 Vaccine, Bivalent booster dose.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (We had 4 patients that received the Moderna Covid-19 vaccine Monovalent, instead of the Moderna Covid-19 Vaccine, Bivalent booster dose.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (We had 4 patients that received the Moderna Covid-19 vaccine Monovalent, instead of the Moderna Covid-19 Vaccine, Bivalent booster dose.).    Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-654131, US-MODERNATX, INC.-MOD-2022-654136 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-654136:same reporter US-MODERNATX, INC.-MOD-2022-654131:same reporter
After administration of COVID-19 vaccine patient complained of chest tightness 2/10 radiating to left arm. Complaining of tongue swelling, nothing observed and airway visibly clear at this time, no rash/urticaria. SBP has increased to >140s, note that she held her beta blocker and has recently diagnosed hypertension. Lungs CTA b/l. We discussed that without decreased blood pressure and wheezing at this time and given her chest pressure we will hold off on epinephrine for now as this is not consistent with suspected anaphylactic reaction but given her hypertension history and chest tightness patient been sent to urgent care at this time. We are giving cetirizine 10 mg and discussed that if objective signs of anaphylaxis clearly epinephrine will be given but with current signs/symptoms further observation where EKG may be done is warranted .Pt in NAD. Appears well, Nontoxic. No respiratory distress at rest, with conversation, or on ambulation. Alert and Oriented times three.  Mental Status clear and coherent.  Normal conversation. Mucous Membranes moist THROAT: No perioral or oral edema noted. Tolerating all secretions. Voice clear NECK: supple, no lymphadenopathy LUNGS: CTA. Good air movement COR: RRR without murmur  No axillary adenopathy No chest wall tenderness to palpation.   Procedures/ EKG EKG: NSR . No ischemic changes. NSTWAs Compared with EKG 12/7/20: No significant change. Slight difference in T wave morphology isolated to V1 (nonspecific)
This case was reported by a healthcare professional via a sales representative and described the occurrence of multiple sclerosis like symptoms in a female subject of unspecified age who was vaccinated with BOOSTRIX (GlaxoSmithKline). On an unspecified date, the subject received unspecified dose of BOOSTRIX (unknown). Within six weeks after vaccination with BOOSTRIX, the subject experienced multiple sclerosis like symptoms and myelin sheath changes. Medical attention was required at a doctor's office. The healthcare professional considered the events were disabling. At the time of reporting the outcome of the events was unspecified.
On day 1 had sx of diffuse myalgias, feet feel puffy like walking on gel, pt looked tired and had trouble making eye contact. On day 8 patient reported tingling/numbness of feet and 9/10 pain in the rest of his body. Was using TYLENOL 1000mg 3-4 times daily, then tried naproxen 400mg twice daily. Patient went to ER on day 9 and was admitted to the hospital. The Neurologist diagnosed him with Guillain Barre associated with PREVNAR 13 administration. He was treated with IVIG. Discharged on day 13. Post discharge patient is recovering with weakness and aching in legs, which is relieved by hydrocodone. Patient is still recovering. Acetaminophen 1000 mg QID, naproxen 440 mg BID, acetaminophen/hydrocodone 1-2 tab every day.
Delayed cutaneous reaction.  Swelling, heat, redness, itch, soreness.  Started 7 days after injection at site.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown ages and genders. On multiple unspecified dates, the patients were inadvertently administered with improperly stored oral ROTATEQ (lot # L029934, expiry date: 01-JUL-2017; lot # M004885, expiry date: 23-OCT-2017; lot # L029934, expiry date: 01-MAY-2017) orally. The vaccine was stored at a temperature of 9.9 UC at an unknown time frame. Data logger was involved and there was no previous temperature excursion. No adverse effect reported. The outcome of the events was not reported. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of vaccination site warmth (warm), pruritus (itchy) and rash on arm in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concurrent medical conditions included a mental impairment. On Apr 5, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 17, 2021, patient experienced vaccination site warmth (warm), pruritus (itchy) and rash on arm. The patient treated with Zyrtec (cetirizine hydrochloride) on Apr 19, 2021; 1 dosage form. At the time of the report, vaccination site warmth (warm), pruritus (itchy) and rash on arm outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medications not provided.
After waiting in the store 15 minutes, patient drove home. By the time she got home she couldn't move her arm. She has been taking ibuprofen for pain. She states the range of motion has gotten better, but isn't yet back to normal and she still has pain. When injecting there was an unusual amount of resistance on the plunger.
I had blood drawn yesterday in left arm  annual health exam  and the blood draw site hurt yesterday no big deal but it was more than usual Next day left arm and muscle upper arm aches.
66 y.o. female patient of Dr. here today for evaluation of pain and swelling in her left upper arm.  She had a wellness visit yesterday and received the PNEUMOVAX 23. Couple hours later she started having some pain and swelling. She took some ibuprofen last night which helped a little bit. It's been moderately achy for her since. She denies any swelling of her lips, tongue. She's not had a scratchy or sore throat or voice change. She denies cough or wheeze. She had some abdominal cramping this morning which was relieved by a bowel movement she should be small to what she ate yesterday. There's been no fever or chills otherwise is feeling okay. Musculoskeletal? left upper arm is moderately swollen, mildly red, warm and mildly tender everything is inferior to where she received the injection. There is no injection site hematoma extremity is otherwise benign looking.
On 10/02/2022, I felt like spikes being hammered on the left side of my head, and they would come and go. It continued for several days. I went to my chiropractor on 10/04/2022. They did an adjustment and they attributed to a side effect of the booster. On the 10/11/2022 I went to my doctor and the doctor agreed it was probably a side effect of the booster and told me to take Tylenol to help with the pain. On 10/14/2022, I was exposed to COVID-19 and on 10/18/2022 I tested positive for COVID-19. I was starting to feel achy and very tired and had a headache, and just slept. The next day I contacted my doctor through telehealth. My head was fuzzy. The doctor prescribed Malnupiravir because she thought it would have less side effects than the Paxlovid. I never quite recovered. I started to feel a little better that I went to my dentist on 10/31/2022. I had laser surgery on 11/1/2022. The next day, I got RSV and I was kind of down again. I had never fully recovered from COVID and then on top of this, RSV. Then I developed bronchitis on 11/6/2022. I never felt like I completely got. I tested positive for influenza A on 11/8/2022. At that point the doctor prescribed Doxycycline for the bronchitis. Currently I still have a lot of fatigue and a cough. My smell and taste has come back a little, but not completely at all. I have about 4 more days of the Doxycycline. I have had this brain fog, fuzzy, dizzy, I have had a difficulty with memory and concentration.
15 minutes after the shot, I became lightheaded in the waiting area and felt like I was going to black out.  I seemed fine after, and shrugged it off as I sometimes experience this on a rare occasion. Thought it was my anxiety from all the drama hearing about side effects. They kept me for 40 minutes and asked me a few questions and felt that I looked and acted normal.  My ride home, my vision seemed "off" and again, I shrugged it off to anxiety.  I also had light heart palpitations.  I get these sometime when I'm stressed, overly tired, too much coffee, or have anxiety.  I wasn't dizzy at all, but my balance felt a tad "off"  I was much better in the morning and back to normal within about 24hrs.   I am worried about geting my 2nd shot as I read people being dizzy and with super high blood pressures......  Hoping these "symptoms" were just from myself getting worked up about..... possible side effects and allergic reactions.
At 1:15 pt started having: Hot face; Tingling lips, face; Swollen eye lids.
Pt came in to UC today with a injection site reaction (rash), after receiving the COVID-19 vaccine x 2 weeks ago (1/13/2021). Pt states the rash developed a small circular rash around the site 1 week ago. She was awakened today with with larger, erythematous rash with mild tenderness to palpation that has now over deltoid and upper arm. Otherwise,  she reports feeling malaise and fatigue. Denies fever or chills.  Left upper arm site marked. Begin Augmentin and Triamcinolone cream as prescribed. Advised pt to return in 72 hours (Friday 1/29/2021) for site recheck. . Will file reaction report with VAERS.
Patient was admitted on 1/25/2022 because of symptomatic COVID-19 infection as well as transaminitis .  Patient presented emergency department with a complaint of generalized body ache fever as well as headache.  Patient was found to have elevated liver enzymes as well as inflammatory markers.  Testing for COVID-19 infection eventually came back positive.  Patient was not hypoxic and therefore did not qualify for any specific treatment.  Patient was started on IV fluid hydration as well as symptomatic treatment.  Patient continued to improve with almost complete resolution of his symptoms.
Patient representative reported that the following day the patient encountered severe congestion and headache, patient reported to the hospital and had a seizure. Patient was placed into a medical coma and airlifted to larger medical center.
On day 8 where day 1 was day of injection the injection site increased in redness and was warm and itchy.